A Multicenter Clinical Trial Evaluating the Efficacy and Safety of Taurine as an Adjunctive Therapy in Multiple Sclerosis

Clinical trial NCT07263607 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07263607
Sponsor: Sichuan Academy of Medical Sciences
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis (MS) Relapsing Remitting

Start date: 2026-01-01
Primary completion: 2029-07-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.